Pharmaresearch's stock price is on the rise. The expectation of export growth in other business divisions due to the brand awareness of Rejuran appears to be influencing the stock price.


[Featured Stock] PharmaResearch Hits 52-Week High on Export Growth Expectations Fueled by Rejuran View original image

At 9:32 AM on the 14th, Pharmaresearch was trading at 180,000 KRW, up 4.47% from the previous day.


Hot Picks Today

"Wow, Have Middle-Aged Men Had This All to Themselves?"... Women in Their 20s and 30s Find Comfort in a Standing Drink "Wow, Have Middle-Aged Men Had This All to Themselves?"... Women in Their 20s and 30s Find Comfort in a Standing Drink

Jeong Heeryeong, a researcher at Shinhan Investment Corp., said, "The export growth of other business divisions driven by the brand awareness of Rejuran in the second quarter is encouraging," adding, "It is necessary to assign a premium to the scalability of the Rejuran brand." He further analyzed, "At this stage, all business divisions are growing within diversified export countries, making it possible to apply a price-earnings ratio (PER) of 25 times."


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing